PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy
Articolo
Data di Pubblicazione:
2012
Citazione:
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy / Martelli, A.M., Tabellini, G., Ricci, F., Evangelisti, C., Chiarini, F., Bortul, R., Mccubrey, J.A., Manzoli, F.A.. - In: ADVANCES IN BIOLOGICAL REGULATION. - ISSN 2212-4926. - 52:1(2012), pp. 214-227. [10.1016/j.advenzreg.2011.09.019]
Tipologia CRIS:
Articolo su rivista
Keywords:
Blotting, Western; Cell Proliferation; Cell Survival; Cells, Cultured; Humans; Interleukin-7; Interleukin-9; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinase Kinases; Multiprotein Complexes; Phosphatidylinositol 3-Kinases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases
Elenco autori:
Martelli, Alberto M; Tabellini, Giovanna; Ricci, Francesca; Evangelisti, Camilla; Chiarini, Francesca; Bortul, Roberta; Mccubrey, James A; Manzoli, Francesco Antonio
Link alla scheda completa:
Titolo del libro:
Advances in Enzyme Regulation
Pubblicato in: